Hepatic parenchymal heterogeneity on contrast-enhanced ct scans following oxaliplatin-based chemotherapy: Natural history and association with clinical evidence of sinusoidal obstruction syndrome

Radiology

Volumn 276, Issue 3, 2015, Pages 766-774

  Han, Na Yeon ^a   Park, Beom Jin ^a   Kim, Min Ju ^a   Sung, Deuk Jae ^a   Cho, Sung Bum ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; PLATINUM COMPLEX;

ADULT; AGED; ANALYTICAL PARAMETERS; APPENDIX CANCER; ARTICLE; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BILE DUCT CARCINOMA; BLOOD FREE HEPATIC PARENCHYMAL ATTENUATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DUODENUM CANCER; FEMALE; HISTORY; HUMAN; IMAGE ANALYSIS; LIVER DISEASE; LIVER METASTASIS; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OXALIPLATIN BASED CHEMOTHERAPY; PANCREAS CANCER; POSTOXALIPLATIN HETEROGENEITY OF LIVER PARENCHYMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; RETROSPECTIVE STUDY; SPLEEN SIZE; STOMACH CANCER; THROMBOCYTE COUNT; CHEMICALLY INDUCED; LIVER; LIVER NEOPLASMS; LIVER VEIN OBSTRUCTION; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84940843621     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015141749     Document Type: Article

References (30)

1. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 2005;23(33):8490-8499.
2. Wang CC, Li J. An update on chemotherapy of colorectal liver metastases. World J Gastroenterol 2012;18(1):25-33.
3. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371(9617):1007-1016.
4. Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 2006;13(1):58-65.
5. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24(13):2065-2072.
6. Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 2010;17(11):2870-2876.
7. Tamandl D, Klinger M, Eipeldauer S, et al. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann Surg Oncol 2011;18(2):421-430.
8. Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006;24(31):4983-4990.
9. Soubrane O, Brouquet A, Zalinski S, et al. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatinbased chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 2010;251(3):454-460.
10. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007;11(7):860-868.
11. Rubbia-Brandt L, Lauwers GY, Wang H, et al. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 2010;56(4):430-439.
12. Overman MJ, Maru DM, Charnsangavej C, et al. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 2010;28(15):2549-2555.
13. Klinger M, Eipeldauer S, Hacker S, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 2009;35(5):515-520.
14. Nakano H, Oussoultzoglou E, Rosso E, et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008;247(1):118-124.
15. Shin NY, Kim MJ, Lim JS, et al. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 2012;22(4):864-871.
16. Ward J, Guthrie JA, Sheridan MB, et al. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxideenhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 2008;26(26):4304-4310.
17. O'Rourke TR, Welsh FK, Tekkis PP, et al. Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection. Eur J Surg Oncol 2009;35(10):1085-1091.
18. Bethke A, Kühne K, Platzek I, Stroszczynski C. Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomography. Cancer Imaging 2011;11:91-99.
19. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004;231(2):482-490.
20. Cuenod C, Leconte I, Siauve N, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001;218(2):556-561.
21. Bennett JJ, Cao D, Posner MC. Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases. J Surg Oncol 2005;92(1):64-69.
22. Mayo-Smith WW, Gupta H, Ridlen MS, Brody JM, Clements NC, Cronan JJ. Detecting hepatic lesions: the added utility of CT liver window settings. Radiology 1999;210(3):601-604.
23. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239(1):105-112.
24. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518-526.
25. Lewis JH, Kleiner DE. Hepatic injury due to drug, herbal compounds, chemicals and toxins. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's pathology of the liver. 6th ed. Edinburgh, Scotland: Churchill Livingstone Elsevier, 2012; 645-760.
26. Han NY, Park BJ, Sung DJ, et al. Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid-enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation. Radiology 2014;271(2):416-425.
27. Uchino K, Fujisawa M, Watanabe T, et al. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report. Jpn J Clin Oncol 2013;43(10):1034-1038.
28. Arakawa Y, Shimada M, Utsunomya T, et al. Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res 2013;43(6):685-689.
29. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15(3):460-466.
30. Gallix BP, Reinhold C, Dauzat M, Bret PM. Streamlined flow in the portal vein: demonstration with MR angiography. J Magn Reson Imaging 2002;15(5):603-609.